Catherine Deneuve Hospitalized in Paris After Minor Stroke

Click here to read the full article.

UPDATED: French screen icon Catherine Deneuve has been hospitalized in Paris following a minor stroke.

Deneuve’s family told Agence-France Presse on Wednesday that the 76-year-old actress had suffered a “very limited” ischemic stroke. Such strokes are caused by reduced blood flow to the brain.

More from Variety

A source with knowledge of the situation said Deneuve had the stroke while filming a scene in a hospital in Gonesse, near Paris, for the movie “De Son Vivant,” which is being directed by Emmanuelle Bercot. Deneuve is now at the Salpetriere hospital, which specializes in treating strokes.

“De Son Vivant” has been shooting for the past three weeks. Production has now been suspended.

Newspaper Le Parisien first broke the news Wednesday of Deneuve’s hospitalization, saying she was in a “serious state” and in need of “extensive examinations.” But a source told Variety that Deneuve’s associates were reporting that her condition was not alarming. Italian news agency ANSA quoted a source saying the actress had been suffering from “fatigue.”

The star of “The Umbrellas of Cherbourg” and “Indochine” was at the Venice Film Festival earlier this year with Hirokazu Kore-eda’s latest film, “The Truth,” in which she appears alongside Juliette Binoche. The film opened the festival.

Known for her archetypal French beauty and her versatility, Deneuve has been the country’s top movie star since the 1960s. She has worked with some of the world’s greatest directors, such as Luis Bunuel, Francois Truffaut, Manoel De Oliveira, Lars von Trier, and Francois Ozon.

Deneuve was Oscar-nominated for “Indochine,” directed by Regis Wargnier, in 1993, and for a BAFTA in 1969 for Bunuel’s “Belle de Jour,” which was her breakout role. She has won several Cesar awards, which are France’s highest film industry honors and been celebrated with career tributes at many festivals around the world.

Best of Variety

Sign up for Variety’s Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.